Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum

dc.contributor.author	Haase, DA
dc.contributor.author	Nash, RA
dc.contributor.author	Nsanze, H
dc.contributor.author	D'Costa, LJ
dc.contributor.author	Fransen, L
dc.contributor.author	Piot, P
dc.contributor.author	Brunham, RC
dc.date.accessioned	2013-10-14T09:38:15Z
dc.date.available	2013-10-14T09:38:15Z
dc.date.issued	1986-01
dc.identifier.citation	Sex Transm Dis. 1986 Jan-Mar;13(1):53-5.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/3082022
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57604
dc.description.abstract	Ceftriaxone (125 mg) given as a single intramuscular dose without topical therapy was evaluated in seven infants with smear-positive gonococcal ophthalmia neonatorum. Neisseria gonorrhoeae was isolated from the eyes of six infants, and four of these isolates were penicillinase-producing N. gonorrhoeae. Two infants had concomitant ocular infection with Chlamydia trachomatis. All seven infants, when seen at follow-up, showed marked clinical improvement. Conjunctivitis resolved completely in four infants. One infant was lost to subsequent follow-up, while two infants had persistent ophthalmia due to C. trachomatis. Follow-up eye cultures for N. gonorrhoeae were all negative.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum	en
dc.type	Article	en